| Name | Title | Contact Details |
|---|
To be the Best Community Healthcare System in New England. About Rutland Regional Medical Center The biggest community hospital in Vermont and the second largest hospital in the state, Rutland Regional Medical Center has been providing high quality healthcare to the Rutland Region for more than 100 years. As the needs of our community have grown and changed, so has Rutland Regional, adding services, staff and facilities. Today, Rutland Regional Medical Center is a 144 bed hospital, employing over 1,600 professional and support staff including 227 providers trained in 36 specialty areas. Providing preventive, diagnostic, acute and rehabilitative services, Rutland Regional Medical Center serves Rutland County, portions of southern and central Vermont and communities in eastern New York State. The hospital`s medical staff is supported by excellent nurses, high quality diagnostic and ancillary services and a broad array of sophisticated equipment technology, including advanced diagnostic imaging, a top-of-the-line linear accelerator used in the treatment of cancer patients, and a diagnostic Cardiovascular and Angiographic Lab. At Rutland Regional we manage and adapt to change and growth while continuing our focus on a high standard of personalized, quality medical care, adding key specialties to serve community needs, and focusing on attracting and recruiting highly trained doctors, nurses and staff. We are committed to providing the services, both in and out of the hospital, required to maintain the health of not just our patients, but the entire community
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
Essilor Canada Ltd. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Derma Sciences, Inc. (Derma Sciences) engages in the manufacture, marketing, and sale of three dermatological related product lines: wound care, wound closure, and specialty securement devices and skin care.
WISH Center, The is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.